LB Pharmaceuticals Inc Common Stock (LBRX) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in New York, NY, United States. The current CEO is Zachary Prensky.
LBRX has IPO date of 2025-09-11, 16 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $835.01M.
No company description available.
